Login to BlackFacts.com using your favorite Social Media Login. Click the appropriate button below and you will be redirected to your Social Media Website for confirmation and then back to Blackfacts.com once successful.
Enter the email address and password you used to join BlackFacts.com. If you cannot remember your login information, click the “Forgot Password” link to reset your password.
[WHO-AFRO] Brazzaville -- In November 2020, the novel Oral Polio Vaccine type 2 (nOPV2) became the first vaccine to be authorized under the WHO Emergency Use Listing. The vaccine has since been rolled out for limited initial use in countries to tackle vaccine-derived poliovirus. Dr Richelot Ayangma, Medical Officer and nOPV2 Focal Point at the WHO Regional Office for Africa explains the vital role of the vaccine in ending all forms of polio and what countries must do to ensure effective vaccination campaigns.
Sorry that there are no other Black Facts here yet!
This Black Fact has passed our initial approval process but has not yet been processed by our AI systems yet.
Once it is, then Black Facts that are related to the one above will appear here.